MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-02-0029814
MMC Pharmaceuticals Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹52.03 Cr
▼ 8% YoY
Net profit · FY 2024
₹2.8 Lakh
Net margin 0.1%
EBITDA · FY 2024
₹86.11 Lakh
EBITDA margin 1.7%
Authorised capital
₹70 Lakh
Registered with MCA
Paid-up capital
₹61.35 Lakh
Issued & subscribed
Open charges
₹9.6 Cr
Satisfied ₹2.35 Cr
Company age
10 yrs
Est. 2016
Employees · EPFO
281
Provident fund records
About MMC Pharmaceuticals Limited
Data last updated:
MMC Pharmaceuticals Limited is a public limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2016PLC104768. Its GSTIN is 33AAKCM2345M1ZA (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹61.35 Lakh. It is led by directors including Malliah Rajarathinam (Managing Director) and Shanthi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No: 113 Visalakshi Street Devi Karumariamman Nagar Valasaravakkam, Chennai, Tamil Nadu, India – 600087.
As per the financials filed for FY 2024, the company reported a revenue of ₹52.03 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.8 Lakh (net margin 0.1%) and EBITDA of ₹86.11 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 3% over five years.
The company has about 281 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: MMC Pharma. As per MCA filings, the company has open charges of ₹9.6 Cr and satisfied charges of ₹2.35 Cr on record. Court records list 12 cases involving the company, including 12 filed by the company. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹56.1 Lakh; the latest was in September 2024. Its 3 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 2 smaller; the largest is Farmachem Private Limited with revenue of ₹52.19 Cr.
MMC Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0029814). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mmcpharmaceuticals.com.
Company details
CIN U24100TN2016PLC104768
Registration Number 104768
Incorporation Date 18 March 2016
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-02-0029814
Key People
Malliah Rajarathinam Managing Director Shanthi Director Rajarathinam Vallab Subash Director Recognitions & Rankings of MMC Pharmaceuticals
Contact details
MMC Pharmaceuticals Limited's registered office is in Chennai, Tamil Nadu. Its website is mmcpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo: 113 Visalakshi Street Devi Karumariamman Nagar Valasaravakkam, Chennai, Tamil Nadu, India – 600087
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of MMC Pharmaceuticals Limited, buy the company report.
Comprehensive company report
MMC Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
MMC Pharmaceuticals operates one associated brand: MMC Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical marketing and sales in domestic and international markets by MMC Pharma. | mmcpharmaceuticals.com |
Business activity
The main business activity of MMC Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of MMC Pharmaceuticals Limited, buy the company report.
Financials of MMC Pharmaceuticals Limited
FY 2024 filings availableMMC Pharmaceuticals Limited reported revenue of ₹52.03 Cr (down 8% YoY) for FY 2024.
Revenue · FY 2024
₹52.03 Cr ▼ 8%
Net profit · FY 2024
₹2.8 Lakh margin 0.1%
EBITDA · FY 2024
₹86.11 Lakh margin 1.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 13%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 49%
3 years · compounded
▼ 4%
5 years · compounded
▼ 10%
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹86.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of MMC Pharmaceuticals Limited, buy the company report.
Board of directors of MMC Pharmaceuticals Limited
MMC Pharmaceuticals has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shanthi | Director | 18 Mar 2016 | 10 Years 7 Months | Current |
| Rajarathinam Vallab Subash Also directs: Aura & Sara Healthcare LLP, Sri Devi Distributors Private Limited | Director | 18 Mar 2016 | 10 Years 7 Months | Current |
| Sureshbabu Makam Also directs: Sakksa Pharma Private Limited, Surax Research Labs Private Limited, Roorkee Research & Analytical Labs Private Limited and 1 more | Director | 24 Dec 2018 | 7 Years 10 Months | Current |
| Malliah Rajarathinam Also directs: MMC Healthcare (Himachal Pradesh) Private Limited | Managing Director | 18 Mar 2016 | 10 Years 7 Months | Current |
| Girijadevi Jayaraman | Director | 21 Mar 2016 | 10 Years 7 Months | Current |
| Malliah Vidyavathi | Director | 21 Mar 2016 | 10 Years 7 Months | Current |
Peer comparison
MMC Pharmaceuticals Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Farmachem Private Limited | ₹52.19 Cr (FY 2025) | 17.0% | Telangana, India | |||
| MMC Pharmaceuticals Limitedthis company | ₹52.03 Cr (FY 2024) | ₹2.8 Lakh | 0.1% | -8.0% | 281 | Chennai, Tamil Nadu, India |
| Vatika Distributors Private Limited | ₹51.65 Cr (FY 2025) | 8.0% | Kolkata, West Bengal, India | |||
| Metrix Healthcare Private Limited | ₹51.51 Cr (FY 2017) | 31.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of MMC Pharmaceuticals Limited, buy the company report.
Auditor
MMC Pharmaceuticals Limited is audited by MADHUKAAR & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MADHUKAAR & ASSOCIATES | FY 2023 | 012339S |
Shareholding
The shareholding of MMC Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of MMC Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹9.6 Cr
Satisfied charges
₹2.35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 May 2018 | 100198603 | Others | ₹9.6 Cr | Open | |
| 27 Mar 2017 | 100127022 | State Bank of India | ₹2.35 Cr | Satisfied |
To see the full charge records of MMC Pharmaceuticals Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
MMC Pharmaceuticals Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹56.1 Lakh; the latest was in September 2024.
Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹56.1 Lakh
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Funding round | ₹56.1 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
MMC Pharmaceuticals Limited has 12 court cases on record: 12 filed by MMC Pharmaceuticals. All cases are disposed.
Total cases
12
Filed by the company
12
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 12 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Writ petition | Filed by the company against an individual | Disposed |
| Madras High Court | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| High Court, TAMIL NADU | Appeal | Filed by the company against Lincs Pharma and 2 Others and 2 others | Disposed |
| High Court, TAMIL NADU | Original application | Filed by the company against Innov4 Sight Health and Biomedical Systems, Rep.By Its Director, | Disposed |
| High Court, TAMIL NADU | Civil suit | Filed by the company against Lincs Pharma and 5 others | Disposed |
To see the full case history of MMC Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for MMC Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
MMC Pharmaceuticals Limited has a workforce of 281 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
281
Active EPFO establishments
1
Employee growth
-4.1%
GST
MMC Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAKCM2345M1ZA | Tamil Nadu | Active | 01 Jul 2017 |
| 34AAKCM2345M1Z8 | Puducherry | Active | 01 Oct 2022 |
To see the full GST registrations and return filing status of MMC Pharmaceuticals Limited, buy the company report.
Recent activity
MMC Pharmaceuticals Limited has 9 board changes on record since 2016: 6 appointments and 3 cessations. The latest: Mariappan Ravichandran ceased to be Director on 09 Sep 2024.
Charges
A charge with Others of Rs. 960.00 Lakh registered on 25 May 2018 with Charge ID 100198603 was modified on 21 Mar 2025.
AGM
Mmc Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Mariappan Ravichandran ceased to be Director.
Filing
Mmc Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Ceased
Ramasamy Savrirajan Jayaraman ceased to be Director.
Ceased
Sureshbabu Makam ceased to be Additional Director.
Appointed
Sureshbabu Makam was appointed as Director.
Charges
A charge registered on 27 Mar 2017 via Charge ID 100127022 with State Bank Of India was fully satisfied on 02 Jun 2018.
Charges
A charge with Others amounted to Rs. 960.00 Lakh with Charge ID 100198603 was registered on 25 May 2018.
Charges
A charge with State Bank Of India of Rs. 235.00 Lakh registered on 27 Mar 2017 with Charge ID 100127022 was modified on 04 Nov 2017.
Charges
A charge with State Bank Of India amounted to Rs. 235.00 Lakh with Charge ID 100127022 was registered on 27 Mar 2017.
Appointed
Girijadevi Jayaraman was appointed as Director.
5 earlier events are in the company report.
Frequently asked questions
MMC Pharmaceuticals is an active public limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 March 2016 (10+ years old) and is registered under CIN U24100TN2016PLC104768.
MMC Pharmaceuticals has 6 current directors:
- Malliah Rajarathinam - Managing Director
- Shanthi - Director
- Rajarathinam Vallab Subash - Director
- Sureshbabu Makam - Director
- Girijadevi Jayaraman - Director
- Malliah Vidyavathi - Director
The latest financial statements of MMC Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of MMC Pharmaceuticals is 33AAKCM2345M1ZA, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 34AAKCM2345M1Z8 (Puducherry).
The CIN (Corporate Identification Number) of MMC Pharmaceuticals is U24100TN2016PLC104768. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MMC Pharmaceuticals has 12 court cases on record: 12 filed by the company.
MMC Pharmaceuticals was incorporated on 18 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.
MMC Pharmaceuticals has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹56.1 Lakh; the latest was in September 2024.
The peers of MMC Pharmaceuticals by revenue are Farmachem Private Limited, Vatika Distributors Private Limited, Metrix Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Mariappan Ravichandran ceased to be Director on 09 Sep 2024. Ramasamy Savrirajan Jayaraman ceased to be Director on 10 Jun 2021. Sureshbabu Makam ceased to be Additional Director on 24 Sep 2019. MMC Pharmaceuticals has 9 board changes on record in total.
Yes, MMC Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-02-0029814).